BML Capital Management, LLC — 13F Holdings & Portfolio
CIK 1616824 · latest 13F-HR filed 2026-05-06
BML Capital Management, LLC manages $155.8M in 13F-reported U.S. long-equity assets across 16 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are ACRS (34.31%), AVIR (24.38%), ORMP (6.91%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 3 new positions, exited 1, added to 7, and trimmed 3.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$155.8M
Long-equity book
16
Distinct positions
2026-03-31
Filed 2026-05-06
+3 / −1 / ↑7 / ↓3
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ATEA PHARMACEUTICALS INC$11.2M +42.0%
- ACLARIS THERAPEUTICS INC$10.5M +24.6%
- OUTSET MED INC$5.3M +262.5%
- ORAMED PHARMACEUTICALS INC$1.7M +19.3%
- TARGET CORP$879.4K +24.0%
Top Trims
- INSTIL BIO INC-$1.8M -25.1%
- IMAGENEBIO INC-$217.8K -17.8%
- CONNECT BIOPHARMA HLDGS LTD-$81.8K -7.1%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ACLARIS THERAPEUTICS INC | ACRS | 00461U105 | $53.4M | 34.31% | 14,250,000 | SH |
| 2 | ATEA PHARMACEUTICALS INC | AVIR | 04683R106 | $38.0M | 24.38% | 7,058,657 | SH |
| 3 | ORAMED PHARMACEUTICALS INC | ORMP | 68403P203 | $10.8M | 6.91% | 3,167,231 | SH |
| 4 | TILLYS INC | TLYS | 886885102 | $8.7M | 5.59% | 2,150,000 | SH |
| 5 | OUTSET MED INC | OM | 690145206 | $7.3M | 4.69% | 1,902,201 | SH |
| 6 | PMV PHARMACEUTICALS INC | PMVP | 69353Y103 | $6.6M | 4.24% | 5,320,000 | SH |
| 7 | CARMAX INC | KMX | 143130102 | $6.4M | 4.14% | 155,000 | SH |
| 8 | KEZAR LIFE SCIENCES INC | KZR | 49372L209 | $5.3M | 3.43% | 720,787 | SH |
| 9 | INSTIL BIO INC | TIL | 45783C200 | $5.3M | 3.42% | 645,600 | SH |
| 10 | TARGET CORP | TGT | 87612E106 | $4.5M | 2.92% | 37,500 | SH |
| 11 | KRAFT HEINZ CO | KHC | 500754106 | $2.8M | 1.80% | 125,000 | SH |
| 12 | JANUX THERAPEUTICS INC | JANX | 47103J105 | $2.2M | 1.38% | 154,961 | SH |
| 13 | PLIANT THERAPEUTICS INC | PLRX | 729139105 | $1.9M | 1.25% | 1,546,137 | SH |
| 14 | CONNECT BIOPHARMA HLDGS LTD | CNTB | G23549101 | $1.1M | 0.69% | 408,887 | SH |
| 15 | IMAGENEBIO INC | IMA | 45175G207 | $1.0M | 0.64% | 200,730 | SH |
| 16 | WALMART INC Put | WMT | 931142103 | $329.1K | 0.21% | 335 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-06 | $155.8M | 16 | 0001754960-26-000359 |
| 2025-12-31 | 2026-02-03 | $115.7M | 16 | 0001754960-26-000146 |